Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Pain In Capital	Accumulated Deficit
Balance at Dec. 31, 2021	$ 303,129	$ 4	$ 471,449	$ (168,324)
Balance, shares at Dec. 31, 2021		39,736,914
Net income	4,618
Balance at Mar. 31, 2022	311,084	$ 4	474,786	(163,706)
Balance, shares at Mar. 31, 2022		39,885,816
Balance at Dec. 31, 2021	303,129	$ 4	471,449	(168,324)
Balance, shares at Dec. 31, 2021		39,736,914
Issuance of common stock upon exercise of stock options	93		93
Issuance of common stock upon exercise of stock options, shares		10,099
Issuance of common stock upon vesting of restricted stock, shares		224,000
Shares withheld for taxes	(1,106)		(1,106)
Shares withheld for taxes, shares		(85,197)
Stock-based compensation expense	4,350		4,350
Net income	4,618			4,618
Balance at Dec. 31, 2022	292,338	$ 4	530,448	(238,114)
Balance, shares at Dec. 31, 2022		42,954,820
Issuance of common stock upon exercise of stock options	$ 3		3
Issuance of common stock upon exercise of stock options, shares	713	713
Issuance of common stock upon vesting of restricted stock, shares		3,205
Shares withheld for taxes	$ (10)		(10)
Shares withheld for taxes, shares		(1,307)
Stock-based compensation expense	4,765		4,765
Net income	(30,881)			(30,881)
Balance at Mar. 31, 2023	$ 266,215	$ 4	$ 535,206	$ (268,995)
Balance, shares at Mar. 31, 2023		42,957,431